ADMA Biologics Inc (NASDAQ:ADMA)

4.91
Delayed Data
As of Jun 22
 +0.05 / +1.03%
Today’s Change
2.01
Today|||52-Week Range
5.70
+52.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues3.4M4.7M12.0M4.0M
 
 
 
 
 
Cost of Goods Sold5.7M12.3M13.2M13.5M
 
 
 
 
 
Depreciation And Amortization277.1K836.1K1.5M829.5K
 
 
 
 
 
 
Operating ExpensesGross Income-2.6M-8.4M-2.6M-10.2M
 
 
 
 
 
General Expenses5.8M6.0M2.8M6.3M
 
 
 
 
 
Research And Development1.4M1.8M1.9M1.3M
 
 
 
 
 
Total Operating Expenses11.8M19.2M17.5M20.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.4M-14.4M-5.5M-16.5M
 
 
 
 
 
Extraordinary Charge--0.00-6.3M0.00
 
 
Interest Expense On Debt642.5K783.0K1.2M1.3M
 
 
 
 
 
Other Expenses0.000.00-10.1K7.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.0M-15.2M-13.0M-17.8M
 
 
 
 
 
Net Income-9.0M-15.2M-13.0M-17.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.4M25.8M45.3M45.3M
 
 
 
 
 
Shares To Calculate EPS Diluted16.4M25.8M45.3M45.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.55-$0.59-$0.29-$0.39
 
 
 
 
 
EPS Diluted-$0.55-$0.59-$0.29-$0.39